Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen“) (TSXV:NXH, OTC:NXHSF), a designer and manufacturer of electrolyzers is pleased to announce that
Next Hydrogen Corporation and BioHep Technologies Ltd. Announce Execution of Definitive Agreement for Reverse Takeover Transaction and Concurrent Financing Next Hydrogen Corporation; BioHep Technologies Ltd. Mississauga, Ontario, CANADA
Not for distribution in the U.S. or to U.S. newswire services.
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) Further to the press release dated December 21, 2020, Next Hydrogen Corporation (“
Next Hydrogen” or the
Company ) and BioHep Technologies Ltd. (“
BioHep”), are pleased to announce that, further to their letter of intent dated December 21, 2020, Next Hydrogen and BioHep have entered into a definitive amalgamation agreement dated March 3, 2021 (the “
Amalgamation Agreement”), pursuant to which Next Hydrogen and a newly-formed subsidiary of BioHep will amalgamate to form a subsidiary of BioHep (“
Next Hydrogen Corporation and BioHep Technologies Ltd Announce Execution of Definitive Agreement for Reverse Takeover Transaction and Concurrent Financing – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.
Not for distribution in the U.S. or to U.S. newswire services.
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) Further to the press release dated December 21, 2020, Next Hydrogen Corporation (“
Next Hydrogen” or the “
Company“) and BioHep Technologies Ltd. (“
BioHep”), are pleased to announce that, further to their letter of intent dated December 21, 2020, Next Hydrogen and BioHep have entered into a definitive amalgamation agreement dated March 3, 2021 (the “
Amalgamation Agreement”), pursuant to which Next Hydrogen and a newly-formed subsidiary of BioHep will amalgamate to form a subsidiary of BioHep (“
Amalco”) and the shareholders of Next Hydrogen will receive common shares of BioHep (the “
Transaction”). Upon completion of the Transaction, it is the intention of the parties that BioHep (the “